Healthcare technology investor focused on improving human health and human potential. Before joining SpringTide, Henri supported over $1B in biopharma investments at Royalty Pharma and began his career in healthcare investment banking at Credit Suisse.

He later served as Managing Partner of the 26 Fund, investing in Stanford GSB founders.

Henri earned degrees in Public Policy and Business Administration from Stanford, where he was an Arjay Miller Scholar.